Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Immuron Limited (IMRN)

2.76   0 (0%) 09-20 15:58
Open: 2.8 Pre. Close: 2.76
High: 2.8 Low: 2.75
Volume: 4,545 Market Cap: 13M
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.803 - 2.816 2.816 - 2.828
Low: 2.717 - 2.733 2.733 - 2.747
Close: 2.737 - 2.761 2.761 - 2.782

Technical analysis

as of: 2019-09-20 4:24:40 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.39     One year: 3.88
Support: Support1: 2.23    Support2: 1.86
Resistance: Resistance1: 2.91    Resistance2: 3.32
Pivot: 2.82
Moving Average: MA(5): 2.82     MA(20): 2.79
MA(100): 3.44     MA(250): 5.77
MACD: MACD(12,26): -0.05     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 30.66     %D(3): 34.69
RSI: RSI(14): 45.47
52-week: High: 10.11  Low: 2.23  Change(%): -72.0
Average Vol(K): 3-Month: 21493  10-Days: 568

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
IMRN has closed above bottom band by 31.7%. Bollinger Bands are 73.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to IMRN's normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 4.42
Shares Float (M) 3.12
% Held by Insiders
% Held by Institutions 3.06
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.680
Book Value (p.s.) 1.760
PEG Ratio
Profit Margin -194.05
Operating Margin
Return on Assets (ttm) -32.9
Return on Equity (ttm) -58.7
Qtrly Rev. Growth 52.5
Gross Profit (p.s.) 0.387
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -4.06
P/E Growth Ratio
P/BV 1.57

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.